WCN26-3062 BEYOND ANTICOAGULATION: PLEIOTROPIC EFFECTS OF APIXABAN IN NEPHROTIC SYNDROME AND PRIMARY GLOMERULONEPHRITIS

Read full text Summarise with VIRAT
Authors: I. S. Mykhaloiko
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Nephrotic syndrome (NS) due to primary glomerulonephritis (GN) is associated with a markedly increased risk of venous thromboembolism (VTE) from hypercoagulability, endothelial dysfunction, and hypoalbuminemia. Prophylactic anticoagulation is often advised, traditionally using warfarin, which has limitations such as dietary restrictions, drug interactions, need for INR monitoring, and bleeding risk. Warfarin may also accelerate vascular calcification in chronic kidney disease. Apixaban, a direct oral anticoagulant (DOAC) selectively inhibiting factor Xa, offers predictable pharmacokinetics, fewer interactions, and lower bleeding risk.

Fields of Study & Subjects

Venous Thromboembolism Diagnosis and Management Renal Diseases and Glomerulopathies Blood Coagulation and Thrombosis Mechanisms

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
105596–105596
Publication date
25 March 2026
Language
EN